Go back to Resources

Alterations in the Human Plasma Lipidome in Response to Tularemia Vaccination

Authors:

Volume:

Issue:

Journal:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Go back to Resources

Distinct gene expression signatures comparing latent tuberculosis infection with different routes of Bacillus Calmette-Guerin vaccination

Authors:

Volume:

Pagination:

Issue:

Journal:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Go back to Resources

Metabolomic Signatures Differentiate Immune Responses in Avian Influenza Vaccine Recipients

Authors:

Journal:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Go back to Resources

Erythema and Induration after Mpox (JYNNEOS) Vaccination Revisited

Authors:

Volume:

Pagination:

Issue:

Journal:

PMID:

URL:

DOI:

Keywords:

Go back to Resources

Go back to Resources

Safety and immunogenicity of a single dose of Tdap compared to Td in pregnant women in Mali and 3 its effect on infant immune responses: a single-centre, randomised, double-blind, active-controlled phase 2 study

Authors:

Volume:

Journal:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Go back to Resources

Safety and immunogenicity of fractional doses of Modified Vaccinia Ankara-Bavarian Nordic

Authors:

Secondary:

Location:

URL:

Go back to Resources

Go back to Resources

First Safety & Immunogenicity Data from a FIH, Placebo-controlled, Dose escalation Trial of a Recombinant Vesicular Stomatitis Virus based Lassa Fever Vaccine in Healthy Adults

Authors:

Secondary:

Location:

URL:

Abstract:

Go back to Resources

Go back to Resources

Pharmacokinetics, Safety, and Tolerability of Oxfendazole in Healthy Adults in an Open-Label Phase 1 Multiple Ascending Dose and Food Effect Study

Authors:

Volume:

Issue:

Journal:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Go back to Resources

Safety and pharmacokinetics of antifungal agent VT-1598 and its primary metabolite, VT-11134, in healthy adult subjects: phase 1, first-in-Human, randomized, double-blind, placebo-controlled study of single-ascending oral doses of VT-1598

Authors:

Journal:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Go back to Resources

A Phase 1, Double-blinded, Placebo-Controlled Clinical Trial to Evaluate the Safety and Immunogenicity of HEV-239 (Hecolin(R)) Vaccine in Healthy US Adults

Authors:

Journal:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources